Instruct: Given the title of a paper, retrieve paper titles that are cited by the given paper.
Query: DrugE-Rank: improving drug–target interaction prediction of new candidate drugs or targets by ensemble learning to rank
Collaborative matrix factorization with multiple similarities for predicting drug-target interactions
A novel integrated action crossing method for drug-drug interaction prediction in non-communicable diseases
Drug drug interaction extraction from the literature using a recursive neural network
Dependency-based long short term memory network for drug-drug interaction extraction
Large-Scale Feature Selection Using Markov Blanket Induction For The Prediction Of Protein-Drug Binding
Dependency-based convolutional neural network for drug-drug interaction extraction
Massively Multitask Networks for Drug Discovery
Representation Learning of Drug and Disease Terms for Drug Repositioning
Enhancing Drug-Drug Interaction Extraction from Texts by Molecular Structure Information
Deep learning of mutation-gene-drug relations from the literature
Drug-Drug Interaction Extraction via Convolutional Neural Networks
Computational drug repositioning through heterogeneous network clustering
DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing
DrugBank: a knowledgebase for drugs, drug actions and drug targets
Inferring new indications for approved drugs via random walk on drug-disease heterogenous networks
Algorithms for Drug Sensitivity Prediction
Diffusion mapping of drug targets on disease signaling network elements reveals drug combination strategies
GrEDeL: A Knowledge Graph Embedding Based Method for Drug Discovery From Biomedical Literatures
Extracting Drug-Drug Interactions with Attention CNNs
Detection of new drug indications from electronic medical records
Enriching domain ontologies using question-answer datasets
Synthetic biology and regulatory networks: where metabolic systems biology meets control engineering
Tools for Gamification Analytics: A Survey
Safety o f Y ttrium-90 I britumomab T iuxetan Radioimmunothera py f or R elapsed L ow-Grade, F ollicular, o r Transformed N on-Hodgkin's L ymphoma
One-Class Collaborative Filtering